Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Akebia Therapeutics, Inc. | 31,143 | reported | 05 Jun 2020 | tx 8+126,288 |
| FATE THERAPEUTICS INC | 25,000 | reported | 02 May 2017 | tx 4+70,000 |
| BIOMARIN PHARMACEUTICAL INC | 13,550 | reported | 20 May 2025 | tx 3+13,550 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 2,384 | reported | 08 May 2026 | tx 3+4,466 |
| KERYX BIOPHARMACEUTICALS INC | 0 | reported | 12 Dec 2018 | tx 5+90,000−90,000 |
| IMMUNOGEN INC | 0 | reported | 12 Feb 2024 | tx 50+11,078,674−11,453,774 |
| LogicBio Therapeutics, Inc. | 0 | reported | 16 Nov 2022 | tx 8+50,842−18,342 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 May 2026 | GRANT_AWARD | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 1,438 | 177.62 USD | |
| 02 Jun 2025 | GRANT_AWARD | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 946 | 135.04 USD | |
| 02 Jun 2025 | GRANT_AWARD | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 2,082 | 135.04 USD | deriv |
| 20 May 2025 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 6,650 | 0.00 USD | |
| 21 May 2024 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 4,720 | 0.00 USD | |
| 12 Feb 2024 | OTHER | IMMUNOGEN INC | 584,397 | — | |
| 12 Feb 2024 | OTHER | IMMUNOGEN INC | 102,466 | — | deriv |
| 12 Feb 2024 | OTHER | IMMUNOGEN INC | 140,357 | — | deriv |
| 12 Feb 2024 | OTHER | IMMUNOGEN INC | 196,875 | — | deriv |
| 12 Feb 2024 | OTHER | IMMUNOGEN INC | 1,100,000 | — | deriv |
| 12 Feb 2024 | OTHER | IMMUNOGEN INC | 1,100,000 | — | deriv |
| 12 Feb 2024 | OTHER | IMMUNOGEN INC | 922,400 | — | deriv |
| 12 Feb 2024 | OTHER | IMMUNOGEN INC | 925,000 | — | deriv |
| 02 Feb 2024 | EXERCISE | IMMUNOGEN INC | 51,234 | 0.00 USD | |
| 05 Feb 2024 | SALE | IMMUNOGEN INC | 20,107 | 29.28 USD | |
| 02 Feb 2024 | EXERCISE | IMMUNOGEN INC | 51,234 | 0.00 USD | deriv |
| 01 Feb 2024 | GRANT_AWARD | IMMUNOGEN INC | 140,357 | 0.00 USD | deriv |
| 27 Dec 2023 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 2,180 | 0.00 USD | |
| 03 Aug 2023 | SALE | IMMUNOGEN INC | 1,020,000 | 16.61 USD | |
| 04 Aug 2023 | EXERCISE | IMMUNOGEN INC | 782,240 | 5.25 USD | |
| 03 Aug 2023 | EXERCISE | IMMUNOGEN INC | 1,017,240 | 4.55 USD | |
| 03 Aug 2023 | EXERCISE | IMMUNOGEN INC | 2,760 | 5.25 USD | |
| 04 Aug 2023 | EXERCISE | IMMUNOGEN INC | 21,978 | 4.55 USD | |
| 02 Aug 2023 | SALE | IMMUNOGEN INC | 986,521 | 17.45 USD | |
| 02 Aug 2023 | EXERCISE | IMMUNOGEN INC | 995,157 | 4.55 USD |